NHS Clinical Entrepreneur Programme Revenue and Competitors

Chelmsford, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • NHS Clinical Entrepreneur Programme's estimated annual revenue is currently $101.6M per year.(i)
  • NHS Clinical Entrepreneur Programme's estimated revenue per employee is $435,998

Employee Data

  • NHS Clinical Entrepreneur Programme has 233 Employees.(i)
  • NHS Clinical Entrepreneur Programme grew their employee count by 23% last year.

NHS Clinical Entrepreneur Programme's People

NameTitleEmail/Phone
1
NHS Clinical EntrepreneurReveal Email/Phone
2
NHS Clinical Entrepreneur Cohort 8Reveal Email/Phone
3
NHS Clinical EntrepeneurReveal Email/Phone
4
Cohort 8 2024-25Reveal Email/Phone
5
NHS Clinical EntrepreneurReveal Email/Phone
6
NHS clinical entrepreneurReveal Email/Phone
7
Medical DoctorReveal Email/Phone
8
Patient EntrepreneurReveal Email/Phone
9
Clinical EntrepreneurReveal Email/Phone
10
NHS Clinical EntrepreneurReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.8M50-4%N/AN/A
#2
$42.8M1445%N/AN/A
#3
$10.8M50-26%N/AN/A
#4
$54.6M1843%N/AN/A
#5
$62.4M2106%N/AN/A
#6
$27.8M10311%N/AN/A
#7
$6.9M32-20%N/AN/A
#8
$268.4M7102%N/AN/A
#9
$102.3M3035%N/AN/A
#10
$15.3M63-32%N/AN/A
Add Company

What Is NHS Clinical Entrepreneur Programme?

Established in 2016, the Clinical Entrepreneur Programme (CEP) aims to support healthcare staff to develop the commercial skills, knowledge and experience needed to successfully develop and spread innovation, for the benefit for patients, the public, and the wider NHS. The programme offers a range of support including direct education, mentoring, networking, and access to exclusive opportunities, expertise and resources.

keywords:N/A

N/A

Total Funding

233

Number of Employees

$101.6M

Revenue (est)

23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$70.1M2366%N/A
#2
$37.6M24414%N/A
#3
$91.9M2639%$16M
#4
$94.4M26432%N/A
#5
$57.6M307N/AN/A